Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Early Clinical Experience with Delafloxacin: A Case Series
J. Patrik Hornak
,
David Reynoso
Internal Medicine
Research output
:
Contribution to journal
›
Review article
›
peer-review
11
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Early Clinical Experience with Delafloxacin: A Case Series'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Delafloxacin
100%
Early Clinical Exposure
100%
Fluoroquinolones
37%
University of Texas
12%
Galveston
12%
Multidrug-resistant
12%
Europe
12%
Electronic Medical Records
12%
Treatment Failure
12%
Treatment Duration
12%
Emergency Medicine
12%
Side Effect Profile
12%
Adverse Events
12%
Adult Patients
12%
Retrospective Review
12%
Staphylococcus Epidermidis (S. epidermidis)
12%
Soft Tissue Infection
12%
Off-label Indications
12%
Skin Tissue
12%
Ophthalmologist
12%
Community-acquired Pneumonia
12%
Infectious Disease Specialist
12%
New Antibiotics
12%
Periprosthetic Joint Infection
12%
Microsoft Excel
12%
Bacterial Skin Infections
12%
Acute Bacterial Skin
12%
Real-world Clinical Data
12%
Medicine and Dentistry
Delafloxacin
100%
Quinolone Derivative
37%
Adverse Event
12%
Infection
12%
Outpatient
12%
Rehabilitation Engineering
12%
Electronic Patient Record
12%
Treatment Duration
12%
Staphylococcus Epidermidis
12%
Infectious Disease
12%
Community-Acquired Pneumonia
12%
Emergency Medicine Physician
12%
Infectious Arthritis
12%
Bacterial Skin Disease
12%
Soft Tissue Infection
12%
Side Effect
12%
Pharmacology, Toxicology and Pharmaceutical Science
Delafloxacin
100%
Quinolone Derivative
37%
Adverse Event
12%
Infection
12%
Community Acquired Pneumonia
12%
Staphylococcus Epidermidis
12%
Soft Tissue Infection
12%
Bacterial Skin Disease
12%
Infectious Arthritis
12%
Diseases
12%
Side Effect
12%